Sarepta Therapeutics (SRPT) said a third patient has died from acute liver failure after receiving one of its gene therapies, intensifying scrutiny over the safety of its treatments, Bloomberg ...

UnitedHealth stock is deeply oversold, undervalued, and primed for a recovery. Read why analysts forecast UNH to have a ~29% ...

The Federal Trade Commission set aside orders barring Hess CEO John Hess from joining Chevron's board and former Pioneer ...

Teledyne (TDY) stock shines in digital imaging, drones, and defense, but stock potential seems priced in. Explore diversified ...

Permian Resources delivers high margins, strong FCF, and low valuation through disciplined operations in the Delaware Basin.

Inhibrx Biosciences rises on early clinical success; Ozekibart shows promise in colorectal cancer. Read here for an analysis ...

SoFi Technologies shows strong growth, expanding margins, and potential for $1B in earnings by FY '27, pointing to a major ...

President Donald Trump has authorized the Justice Department to seek the release of grand jury testimony related to the ...

Having passed the midpoint of the year, several of our key economic predictions for 2025 are on track, including weaker US ...

Learn how Vltava Fund builds resilient portfolios for long-term gains. Understand why equities beat inflation — and how ...

The dollar’s fall and stretched growth valuations set the stage for small-cap value upside. Learn why Miller Value thinks now ...

Next week, we have the ECB meeting on July 24. Although we don’t see a cut, we will be listening for hints about the path ...